These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro inhibition of xanthine oxidase by azapropazone and 8-hydroxy-azapropazone. Jahn U; Thiele K Arzneimittelforschung; 1988 Apr; 38(4):507-8. PubMed ID: 3401265 [TBL] [Abstract][Full Text] [Related]
4. A study of the potential interactions between azapropazone and frusemide in man. Williamson PJ; Ene MD; Roberts CJ Br J Clin Pharmacol; 1984 Oct; 18(4):619-23. PubMed ID: 6487503 [TBL] [Abstract][Full Text] [Related]
5. Endoscopic evaluation of the effect of azapropazone on the gastric mucosa. Hradsky M; Bruce L Scand J Rheumatol; 1978; 7(1):31-2. PubMed ID: 675173 [TBL] [Abstract][Full Text] [Related]
6. Interaction between azapropazone and warfarin. Powell-Jackson PR Br Med J; 1977 May; 1(6070):1193-4. PubMed ID: 861532 [No Abstract] [Full Text] [Related]
7. Pharmacokinetic investigation of the interaction of azapropazone with phenytoin. Geaney DP; Carver JG; Davies CL; Aronson JK Br J Clin Pharmacol; 1983 Jun; 15(6):727-34. PubMed ID: 6871071 [TBL] [Abstract][Full Text] [Related]
9. The effect of azapropazone on the binding of warfarin to human serum proteins [proceedings]. McElnay JC; D'Arcy PF J Pharm Pharmacol; 1978 Dec; 30 Suppl():73P. PubMed ID: 32332 [No Abstract] [Full Text] [Related]
11. [Kinetics of digitoxin during antirheumatic therapy with azapropazone (author's transl)]. Faust-Tinnefeldt G; Gilfrich HJ Arzneimittelforschung; 1977; 27(10):2009-11. PubMed ID: 579114 [TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory action of azapropazone. Lewis DA; Best R; Bird J J Pharm Pharmacol; 1977 Feb; 29(2):113-4. PubMed ID: 15057 [No Abstract] [Full Text] [Related]
13. The pharmacology and pharmacokinetics of azapropazone - a review. Jones CJ Curr Med Res Opin; 1976; 4(1):3-16. PubMed ID: 770078 [TBL] [Abstract][Full Text] [Related]
14. [The potentiating effects of azathioprine and azapropazone on the enzyme activity in experimental inflammation]. Stojan B Z Rheumatol; 1976; 35(1-2):18-23. PubMed ID: 176844 [TBL] [Abstract][Full Text] [Related]
15. Effect of azapropazone and allopurinol on myocardial infarct size in rats. Montor SG; Thoolen MJ; Mackin WM; Timmermans PB Eur J Pharmacol; 1987 Aug; 140(2):203-7. PubMed ID: 3666017 [TBL] [Abstract][Full Text] [Related]
16. The uricosuric action of azapropazone: dose-response and comparison with probenecid. Higgens CS; Scott JT Br J Clin Pharmacol; 1984 Sep; 18(3):439-43. PubMed ID: 6487482 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of prostaglandin potentiated formalin induced arthritis with non-steroid antiphlogistics. Szántó L; Tanka D; Kellner M Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):113-9. PubMed ID: 1254374 [TBL] [Abstract][Full Text] [Related]
19. The amphiprotic character of azapropazone and its relevance to the gastric mucosa. McCormack K; Brune K Arch Toxicol; 1990; 64(1):1-6. PubMed ID: 2407231 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of azapropazone in the elderly. Ritch AE; Perera WN; Jones CJ Br J Clin Pharmacol; 1982 Jul; 14(1):116-9. PubMed ID: 7104163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]